PATENT CLAIM ANALYSIS

Application Number: 15771210
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["435", "007100"]

Abstract:
Disclosed are systems and methods for detecting the sample concentration of cardiac troponin I (cTnI) and the sample concentration of soluble urokinase receptor (suPAR) to determine if a subject has or is at risk for developing cardiovascular disease or a complication of previously diagnosed cardiovascular disease.

Claim (Index 14):
The system of  claim 13 , further comprising a computer system, wherein said computer system comprises: i) a computer processor for receiving, processing, and communicating data, ii) a storage component for storing data which contains a reference database containing a cTnI control concentration and a suPAR control concentration; and iii) a computer program, embedded within said computer processor, which is configured to process said results of said first and second assays in the context of said reference database to determine, as an outcome, if said subject has or is at risk for developing cardiovascular disease or a complication of cardiovascular disease.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.34211
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12520718', '15062759', '14312298', '13184115', '13798547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6035136000551333
- 35 USC 102 Novelty (BERT): 0.5126879825103805
- Combined Prediction Score: 0.594431038300658
- Mean Citation Score: 263.76421
- Max Citation Score: 282.89346
- Similarity Product: 172.66696087313176

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test